RESUMEN
BACKGROUND: The aim of the present prospective clinical study is to compare the stability of the implant-bone interface by the ISQ quotient and marginal bone loss (MBL) rate during one year of follow-up in four system implants with the same surface and different design. MATERIAL AND METHODS: Prospective randomized clinical trial of 21 patients in which four implant systems with the same surface and different design were placed. Patients were treated by the same operator following a similar surgical protocol with submerged technique. The second surgery to perform the prosthesis was performed at 3 months. All patients went to their review at 6 months and a year. A periapical radiograph for crestal bone analysis and an Implant stability quotient by resonance frequency analysis (ISQ) analysis were taken at baseline and the reviews. RESULTS: No statistically significant differences were found in the Implant stability quotient by resonance frequency analysis and Marginal Bone Loss in the four types of implants. The ISQ increased from the moment of insertion of the implant until the revision to the year, showing an increase of the stability implant, being this increasing less between the 6 months and the year. CONCLUSIONS: Differences in the design of the four implants tested in this study did not show statistically significant differences in any of the variables studied, so the implant design does not influence implant stability and marginal bone loss in the first year after placement.
Asunto(s)
Pérdida de Hueso Alveolar/rehabilitación , Pérdida de Hueso Alveolar/cirugía , Implantes Dentales , Oseointegración , Análisis de Frecuencia de Resonancia/métodos , Anciano , Pérdida de Hueso Alveolar/diagnóstico por imagen , Pilares Dentales , Implantación Dental Endoósea , Implantes Dentales/efectos adversos , Diseño de Prótesis Dental , Prótesis Dental de Soporte Implantado , Femenino , Humanos , Masculino , Mandíbula/diagnóstico por imagen , Mandíbula/cirugía , Maxilar/diagnóstico por imagen , Maxilar/cirugía , Persona de Mediana Edad , Estudios ProspectivosRESUMEN
AIM: To evaluate the effectiveness on tissue response of the new nutritional supplement made of oligomeric proanthocyanidins in induced gingivitis after 21 days of use. MATERIAL AND METHODS: A prospective, double-blind, randomized, controlled clinical trial was carried out on 20 patients; it is divided into an experimental group and a control group after fulfilling the selection criteria. Patients had to come 4 times during the study to register the Silness and Löe index, the gingival bleeding index, the plaque index, the inflammatory crevicular fluid study (IL6), and the changes in the brightness of the gingiva. No complementary hygiene methods were allowed during the 21 days. RESULTS: The Silness and Löe index was higher in the control group than in the experimental group, reaching a twofold difference between the groups (p < 0.0001). The gingival bleeding index also supports this fact, since the bleeding was lower in the experimental group (p < 0.005). However, the dental plaque on the tooth surface according to the plaque index was 33% higher in the experimental group (p < 0.006). Some differences in the IL-6 were found in the crevicular fluid (p < 0.0001). CONCLUSION: Oligomeric proanthocyanidins have an effect on the periodontal tissue's health. No effects on the accumulation of plaque on the tooth surface were found, so further studies are needed to determine the nature of the plaque.
Asunto(s)
Gingivitis/prevención & control , Proantocianidinas/administración & dosificación , Adulto , Placa Dental/prevención & control , Suplementos Dietéticos , Método Doble Ciego , Femenino , Humanos , Interleucina-6/análisis , Masculino , Estudios ProspectivosRESUMEN
The purpose of this work is to evaluate radiation doses to the lens of urologists during interventional procedures and to compare them with values measured during interventional radiology, cardiology and vascular surgery. The measurements were carried out in a surgical theatre using a mobile C-arm system and electronic occupational dosimeters (worn over the lead apron). Patient and staff dose measurements were collected in a sample of 34 urology interventions (nephrolithotomies). The same dosimetry system was used in other medical specialties for comparison purposes. Median and 3rd quartile values for urology procedures were: patient doses 30 and 40 Gy cm(2); personal dose equivalent Hp(10) over the apron (µSv/procedure): 393 and 848 (for urologists); 21 and 39 (for nurses). Median values of over apron dose per procedure for urologists resulted 18.7 times higher than those measured for radiologists and cardiologists working with proper protection (using ceiling suspended screens) in catheterisation laboratories, and 4.2 times higher than the values measured for vascular surgeons at the same hospital. Comparison with passive dosimeters worn near the eyes suggests that dosimeters worn over the apron could be a reasonable conservative estimate for ocular doses for interventional urology. Authors recommend that at least the main surgeon uses protective eyewear during interventional urology procedures.
Asunto(s)
Cardiólogos , Cristalino/efectos de la radiación , Nefrostomía Percutánea , Exposición Profesional/análisis , Dosis de Radiación , Radiólogos , Radiología Intervencionista , Urólogos , Humanos , Protección Radiológica , Procedimientos Quirúrgicos VascularesRESUMEN
New European regulation regarding radiological protection of workers and more specifically the new occupational dose limit for the eye lens recently reduced to 20 mSv yr(-1) may affect interventional cardiologists. This paper presents a set of measurements of occupational doses performed in five interventional cardiology centres and then compared with the new dose limit. The measurement of occupational doses was performed over the apron at chest level using electronic dosemeters recording H p(10). In one of the centres, scatter dose at goggles was also measured with optically stimulated luminescence dosemeters calibrated in terms of H p(0.07). An average H p(10) over the apron of 46 µSv/procedure was measured for cardiologists. Lower doses were noted in other professionals like second cardiologists, nurses or anaesthetists. Procedures for valvular and other structural heart diseases involved the highest occupational doses, averaging over 100 µSv/procedure. Important differences in occupational doses among centres may be indicative of different radiation protection habits. The new occupational dose limit for the eye lens is likely to be exceeded by those among the interventionalists who do not use protection tools (ceiling suspended screen and/or goggles) even with standard workloads.
Asunto(s)
Cristalino/efectos de la radiación , Exposición Profesional/análisis , Dosis de Radiación , Protección Radiológica , Radiología Intervencionista , HumanosRESUMEN
This study presents the performance of two fast Monte Carlo codes, PENELOPE/penEasyIR and MCGPU-IR in order to assess operator doses in interventional radiology. In particular, it aims to validate the calculations when workers are protected with shielding located between the patient and the operator. The experiments are performed in a calibration laboratory and measurements are gathered using Thermo EPD and Mirion DMC personal active dosemeters. Calculation efficiency of the fast Monte Carlo codes is approximately four orders of magnitude greater than for a standard Monte Carlo code. Satisfactory agreement between measurements and calculations is shown.
Asunto(s)
Radiología Intervencionista , Radiometría , Humanos , Fantasmas de Imagen , Método de Montecarlo , CalibraciónRESUMEN
A new species belonging to the Dothideomycete genus Acanthostigma is described from bark of two Nothofagus species from Argentina. Its identity as a new species is based on both morphology and molecular sequence data. Acanthostigma patagonica differs from other species in the genus by having larger ascomata and setae and wider, asymmetrical ascospores. An amended key to Acanthostigma species is provided along with a discussion of other species previously described from South America.
Asunto(s)
Ascomicetos/clasificación , Fagaceae/microbiología , Ascomicetos/genética , Ascomicetos/ultraestructura , ADN de Hongos/análisis , ADN de Hongos/genética , ADN Ribosómico/análisis , ADN Ribosómico/genética , Geografía , Datos de Secuencia Molecular , Filogenia , Análisis de Secuencia de ADN , América del Sur , Esporas Fúngicas/ultraestructuraRESUMEN
The objective of this study was to demonstrate the efficacy of intramuscular botulinum toxin type A (BTX-A) as a method of controlling the symptoms of focal facial dystonia. A prospective, longitudinal, observational, pre-post (case-series) single-centre study was conducted over a period of 3 months, involving 30 patients with focal dystonia. The patients were enrolled on a first-come, first-served basis. For all patients, the abnormal movements were evaluated using the Abnormal Involuntary Movement Scale (AIMS). The AIMS results were recorded immediately before BTX-A injection (primary predictor variable) and after 3 months (the toxin reaches its maximum effect 2 weeks after injection, and the effect is maintained for 3 months). An improvement in AIMS score was the primary outcome variable. Treatment efficacy was evaluated using the Pearson correlation index with a level of significance of P<0.05. The average age of the study subjects was 70.9±12.7years (20 female, 10 male). The mean dose of BTX-A used was 27.4±20.5U. The mean improvement in AIMS score after treatment was 5.2±4.2. A significant correlation was found between the dose applied and the reduction in AIMS score (P<0.05). BTX-A can be used in the treatment of focal dystonia and provides reproducible results.
Asunto(s)
Toxinas Botulínicas Tipo A/uso terapéutico , Distonía/tratamiento farmacológico , Parálisis Facial/tratamiento farmacológico , Fármacos Neuromusculares/uso terapéutico , Anciano , Distonía/fisiopatología , Femenino , Humanos , Estudios Longitudinales , Masculino , Estudios Prospectivos , Resultado del TratamientoRESUMEN
We show here that the GTPase RhoG is involved in caveolar trafficking. Wild-type RhoG moves sequentially to the plasma membrane, intracellular vesicles, and the Golgi apparatus along markers of this endocytic pathway. Such translocation is associated with changes in RhoG GDP/GTP levels and is highly dependent on lipid raft integrity and on the function of the GTPase dynamin2. In addition, the constitutively active RhoG(Q61L) mutant is preferentially located in endocytic vesicles that can be decorated with markers of the caveola-derived endocytic pathway. RhoG(Q61L), but not the analogous Rac1 mutant protein, affects caveola internalization and the subsequent delivery of endocytic vesicles to the Golgi apparatus. The expression of RhoG/Rac1 chimeric proteins and RhoG(Q61L) effector mutants in cells induces alterations in the internalization of caveolae and severe changes in vesicle structure, respectively. However, the knockdown of endogenous rhoG transcripts using small interfering RNAs does not affect significantly the trafficking of caveola-derived vesicles, suggesting that RhoG function is dispensable for this endocytic process or, alternatively, that its function is compensated by other molecules. Taken together, these observations assign a novel function to RhoG and suggest that caveolar trafficking, as previously shown for other endocytic routes, is modulated by GTPases of the Ras superfamily.
Asunto(s)
Caveolas/fisiología , Endocitosis/fisiología , Fluoresceína-5-Isotiocianato/análogos & derivados , Proteínas de Unión al GTP rho/fisiología , Animales , Células CHO , Caveolinas/análisis , Caveolinas/fisiología , Toxina del Cólera/análisis , Clatrina/análisis , Clatrina/fisiología , Cricetinae , Cricetulus , Dinamina II/genética , Dinamina II/farmacología , Activación Enzimática , Fluoresceína-5-Isotiocianato/metabolismo , Colorantes Fluorescentes/análisis , Microscopía Fluorescente , Mutación Puntual , Transporte de Proteínas , ARN Interferente Pequeño/farmacología , Proteínas Recombinantes de Fusión/fisiología , Fracciones Subcelulares/química , Transfección , Proteínas de Unión al GTP rho/genéticaRESUMEN
The aim of this study was to evaluate the occupational radiation dose in interventional cardiology by using a shielding drape on the patient. A random study with and without the protective material was conducted. The following control parameters were registered: demographic data, number of stents, contrast media volume, fluoroscopy time, number of cine images, kerma-area product and cumulative air kerma. Occupational dose data were obtained by electronic active dosemeters. No statistically significant differences in the analysed control parameters were registered. The median dose value received by the interventional cardiologist was 50% lower in the group with a shielding drape with a statistically significant p-value <0.001. In addition, the median value of the maximum scatter radiation dose was 31% lower in this group with a statistically significant p-value <0.001. This study showed that a shielding drape is a useful tool for reducing the occupational radiation dose in a cardiac catheterisation laboratory.
Asunto(s)
Cateterismo Cardíaco , Protección Radiológica , Fluoroscopía , Humanos , Exposición Profesional , Dosis de Radiación , Traumatismos por Radiación , Radiografía IntervencionalRESUMEN
BACKGROUND AND PURPOSE: Eye lenses are among the most sensitive organs to x-ray radiation and may be considered at risk during neurointerventional radiology procedures. The threshold dose to produce eye lens opacities has been recently reduced to 500 mGy by the International Commission on Radiologic Protection. In this article, the authors investigated the radiation doses delivered to patients' eyes during interventional neuroradiology procedures at a university hospital. MATERIALS AND METHODS: Small optically stimulated luminescence dosimeters were located over patients' eyes during 5 diagnostic and 31 therapeutic procedures performed in a biplane x-ray system. Phantom measurements were also made to determine the level of radiation to the eye during imaging runs with conebeam CT. RESULTS: The left eye (located toward the lateral C-arm x-ray source) received a 4.5 times greater dose than the right one. The average dose during embolization in the left eye was 300 mGy, with a maximum of 2000 mGy in a single procedure. The patient who received this maximum eye dose needed 6 embolization procedures to treat his high-volume AVM. If one took into account those 6 embolizations, the eye dose could be 2-fold. Sixteen percent of the embolizations resulted in eye doses of >500 mGy. CONCLUSIONS: A relevant fraction of patients received eye doses exceeding the threshold of 500 mGy. A careful optimization of the procedures and follow-up of these patients to evaluate potential lens opacities should be considered.
Asunto(s)
Cristalino/efectos de la radiación , Dosis de Radiación , Radiografía Intervencional/efectos adversos , Embolización Terapéutica/efectos adversos , Embolización Terapéutica/métodos , Femenino , Humanos , Masculino , Persona de Mediana EdadRESUMEN
Hypoxic encephalopathy is the most common cause of neonatal seizures and can lead to chronic epilepsy. In rats at postnatal days 10-12 (P10-12), global hypoxia induces spontaneous seizures and chronically decreases seizure threshold, thus mimicking clinical aspects of neonatal hypoxia. We have shown previously that the acute and chronic epileptogenic effects of hypoxia are age-dependent and require AMPA receptor activation. In this study, we aimed to determine whether hypoxia-induced seizures and epileptogenesis are associated with maturational and seizure-induced changes in AMPA receptor composition and function. Northern and Western blots indicated that glutamate receptor 2 (GluR2) mRNA and protein expression were significantly lower in neocortex and hippocampus at P10-12 compared with adult. After hypoxia-induced seizures at P10, GluR2 mRNA was significantly decreased within 48 hr, and GluR2 protein was significantly decreased within 96 hr. AMPA-induced Co(2+) uptake by neurons in hippocampal slices indicated higher expression of Ca(2+)-permeable AMPA receptors in immature pyramidal neurons compared with adult. In slices obtained 96 hr after hypoxia-induced seizures, AMPA-induced Co(2+) uptake was significantly increased compared with age-matched controls, and field recordings revealed increased tetanus-induced afterdischarges that could be kindled in the absence of NMDA receptor activation. In situ end labeling showed no acute or delayed cell death after hypoxia-induced seizures. Our results indicate that susceptibility to hypoxia-induced seizures occurs during a developmental stage in which the expression of Ca(2+)-permeable AMPA receptors is relatively high. Furthermore, perinatal hypoxia-induced seizures induce increased expression of Ca(2+)-permeable AMPA receptors and an increased capacity for AMPA receptor-mediated epileptogenesis without inducing cell death.
Asunto(s)
Epilepsia/fisiopatología , Hipocampo/fisiopatología , Hipoxia Encefálica/fisiopatología , Receptores AMPA/metabolismo , Envejecimiento/metabolismo , Animales , Animales Recién Nacidos , Calcio/metabolismo , Muerte Celular , Cobalto/farmacocinética , Susceptibilidad a Enfermedades/fisiopatología , Epilepsia/etiología , Regulación del Desarrollo de la Expresión Génica , Hipocampo/efectos de los fármacos , Hipocampo/crecimiento & desarrollo , Hipoxia Encefálica/complicaciones , Hibridación in Situ , Técnicas In Vitro , Masculino , Neocórtex/metabolismo , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Células Piramidales/metabolismo , ARN Mensajero/metabolismo , Ratas , Ratas Long-Evans , Receptores AMPA/genética , Ácido alfa-Amino-3-hidroxi-5-metil-4-isoxazol Propiónico/farmacologíaRESUMEN
Redox-active compounds modulate NMDA receptors (NMDARs) such that reduction of NMDAR redox sites increases, and oxidation decreases, NMDAR-mediated activity. Because NMDARs contribute to the pathophysiology of seizures, redox-active compounds also may modulate seizure activity. We report that the oxidant 5, 5'-dithio-bis(2-nitrobenzoic acid) (DTNB) and the redox cofactor pyrroloquinoline quinone (PQQ) suppressed low Mg(2+)-induced hippocampal epileptiform activity in vitro. Additionally, in slices exposed to 4-7 microM bicuculline, DTNB and PQQ reversed the potentiation of evoked epileptiform responses by the reductants dithiothreitol and Tris(2-carboxyethyl)phosphine (TCEP). NMDA-evoked whole-cell currents in CA1 neurons in slices were increased by TCEP and subsequently decreased by DTNB or PQQ at the same concentrations that modulated epileptiform activity. However, DTNB and PQQ had little effect on baseline NMDA-evoked currents in control medium, and PQQ did not alter NMDAR-dependent long-term potentiation. In contrast, in slices returned to control medium after low Mg(2+)-induced ictal activity, DTNB significantly inhibited NMDAR-mediated currents, indicating endogenous reduction of NMDAR redox sites under this epileptogenic condition. These data suggested that PQQ and DTNB suppressed spontaneous ictal activity by reversing pathological NMDAR redox potentiation without inhibiting physiological NMDAR function. In vivo, PQQ decreased the duration of chemoconvulsant-induced seizures in rat pups with no effect on baseline behavior. Our results reveal endogenous potentiation of NMDAR function via mass reduction of redox sites as a novel mechanism that may enhance epileptogenesis and facilitate the transition to status epilepticus. The results further suggest that redox-active compounds may have therapeutic use by reversing NMDAR-mediated pathophysiology without blocking physiological NMDAR function.
Asunto(s)
Epilepsia/metabolismo , Epilepsia/fisiopatología , Hipocampo/fisiopatología , Receptores de N-Metil-D-Aspartato/fisiología , Animales , Anticonvulsivantes/farmacología , Bicuculina , Factores Quimiotácticos/farmacología , Convulsivantes , Ácido Ditionitrobenzoico/farmacología , Epilepsia/inducido químicamente , Hipocampo/química , Hipocampo/metabolismo , Indicadores y Reactivos/farmacología , Potenciación a Largo Plazo/efectos de los fármacos , Potenciación a Largo Plazo/fisiología , Potenciales de la Membrana/efectos de los fármacos , Oxidación-Reducción , Cofactor PQQ , Técnicas de Placa-Clamp , Pentilenotetrazol , Fosfinas/farmacología , Quinolonas/farmacología , Quinonas/farmacología , Ratas , Ratas Long-Evans , Convulsiones/inducido químicamente , Convulsiones/metabolismo , Convulsiones/fisiopatología , Reactivos de Sulfhidrilo/farmacologíaRESUMEN
Group II phospholipase A2 (sPLA2) has been implicated as an important agent involved in a number of inflammatory processes. Potent pro-inflammatory cytokines, such as interleukin-1 beta (IL-1 beta) and tumor necrosis factor (TNF) have been found to induce sPLA2 synthesis and release from many cell types among which mesangial cells. Although considerable research has been devoted to unravelling the mechanisms underlying the induction of sPLA2 not much is known about the time scale at which the cytokine elicited signals for sPLA2 induction persist in target cells. In this study we addressed that question by using rat renal mesangial cells as a model target cell. We found that after removal of IL-1 beta from the culture medium, the induced-sPLA2 synthesis continues at gradually decreasing rates for approximately 8 h. This is accompanied by a decrease in sPLA2 mRNA levels. Furthermore, with pulse-chase experiments we investigated the half-life of sPLA2 disappearance from the cells. This disappearance was found to be biphasic. A rapidly disappearing pool, constituting approx. 74% of the total, exhibited a half-life of 1.6 +/- 0.2 h. The remaining pool of the induced enzyme was much more stable and its level remained constant for at least 24 h. Analysis of the appearance of newly synthesized enzyme in the culture medium indicated this process to be completed in an hour.
Asunto(s)
Mesangio Glomerular/enzimología , Interleucina-1/metabolismo , Fosfolipasas A/metabolismo , Animales , Northern Blotting , Células Cultivadas , Medios de Cultivo , Electroforesis en Gel de Poliacrilamida , Inducción Enzimática , Mesangio Glomerular/metabolismo , Semivida , Cinética , Fosfolipasas A/biosíntesis , Fosfolipasas A/genética , Fosfolipasas A2 , Pruebas de Precipitina , ARN Mensajero/metabolismo , RatasRESUMEN
The molecular mechanisms by which peroxisome proliferator-activated receptor (PPAR) activation by fibrates reduces fat deposition and improves insulin sensitivity are not completely understood. We report that exposure of a rat primary culture of adipocytes for 24 h to the PPAR activator bezafibrate increased the mRNA levels of crucial genes involved in peroxisomal and mitochondrial beta-oxidation. The mRNA levels of the peroxisomal beta-oxidation rate-limiting enzyme acyl-CoA oxidase and of the muscle-type carnitine palmitoyl transferase I (M-CPT-I), which determines the flux of mitochondrial beta-oxidation, increased by 1.6-fold (P < 0.02) and 4.5-fold (P = 0.001), respectively. These changes were accompanied by an increase in the transcript levels of the uncoupling protein-2 (UCP-2; 1.5-fold induction; P < 0.05) and UCP-3 (3.7-fold induction; P < 0.001), mitochondrial proteins that reduce ATP yield and may facilitate the oxidation of fatty acids. Furthermore, bezafibrate increased the mRNA levels of the fatty acid translocase (2-fold induction; P < 0.01), suggesting a higher fatty acid uptake into adipocytes. In agreement with these changes, bezafibrate caused a 1.9-fold induction (P < 0.02) in 9,10-[(3)H]palmitate oxidation. Moreover, bezafibrate reduced the mRNA expression of several adipocyte markers, including PPARgamma (30% reduction; P = 0.05), tumor necrosis factor-alpha (33% reduction; P < 0.05), and the ob gene (26% reduction). In contrast, adipocyte fatty acid binding protein mRNA levels increased (1.5-fold induction; P < 0.01), pointing to a mobilization of fatty acids to mitochondria and peroxisomes. The reduction of the adipocyte markers caused by bezafibrate was accompanied by an increase in the mRNA levels of the preadipocyte marker Pref-1 (1.6-fold induction; P < 0.01). Some of the changes observed in the primary culture of rat adipocytes also were studied in the epididymal white adipose tissue of bezafibrate-treated rats for 7 days. In vivo, M-CPT-I mRNA levels increased (4.5-fold induction; P = 0.001) in epididymal white adipose tissue of bezafibrate-treated rats. Similarly, fatty acid translocase (2.6-fold induction; P = 0.002) and Pref-1 (5.6-fold induction) mRNA levels increased, although differences in the latter were not significant because of huge individual variations. These results indicate that exposure of adipocytes to bezafibrate, independent of its hepatic effects, increases the degradation of fatty acids, reducing their availability to synthesize triglycerides. As a result, some degree of dedifferentiation of adipocytes to preadipocyte-like cells is achieved. These changes may be involved in the reduction in fat depots and in the improvement of insulin sensitivity observed after bezafibrate treatment.
Asunto(s)
Adipocitos/metabolismo , Bezafibrato/farmacología , Proteínas de Transporte de Membrana , Proteínas Mitocondriales , Transportadores de Anión Orgánico , ARN Mensajero/metabolismo , Transcripción Genética/efectos de los fármacos , Acil-CoA Oxidasa , Adipocitos/efectos de los fármacos , Tejido Adiposo/citología , Tejido Adiposo/metabolismo , Animales , Antígenos CD36 , Carnitina O-Palmitoiltransferasa/genética , Proteínas Portadoras/genética , Células Cultivadas , Epidídimo , Canales Iónicos , Isoenzimas/genética , Masculino , Glicoproteínas de Membrana/genética , Mitocondrias/metabolismo , Oxidorreductasas/genética , Peroxisomas/efectos de los fármacos , Peroxisomas/metabolismo , Proteínas/genética , Ratas , Ratas Sprague-Dawley , Receptores Citoplasmáticos y Nucleares/genética , Factores de Transcripción/genética , Factor de Necrosis Tumoral alfa/genética , Desacopladores , Proteína Desacopladora 2 , Proteína Desacopladora 3RESUMEN
The purpose of this article is to estimate lens doses using over apron active personal dosemeters in interventional catheterisation laboratories (cardiology IC, neuroradiology IN and radiology IR) and to investigate correlations between occupational lens doses and patient doses. Active electronic personal dosemeters placed over the lead apron were used on a sample of 204 IC procedures, 274 IN and 220 IR (all performed at the same university hospital). Patient dose values (kerma area product) were also recorded to evaluate correlations with occupational doses. Operators used the ceiling-suspended screen in most cases. The median and third quartile values of equivalent dose Hp(10) per procedure measured over the apron for IC, IN and IR resulted, respectively, in 21/67, 19/44 and 24/54 µSv. Patient dose values (median/third quartile) were 75/128, 83/176 and 61/159 Gy cm(2), respectively. The median ratios for dosemeters worn over the apron by operators (protected by the ceiling-suspended screen) and patient doses were 0.36; 0.21 and 0.46 µSv Gy(-1) cm(-2), respectively. With the conservative approach used (lens doses estimated from the over apron chest dosemeter) we came to the conclusion that more than 800 procedures y(-1) and per operator were necessary to reach the new lens dose limit for the three interventional specialties.
Asunto(s)
Cardiología/métodos , Cristalino/efectos de la radiación , Exposición Profesional/prevención & control , Exposición Profesional/estadística & datos numéricos , Radiología Intervencionista/métodos , Radiología/métodos , Cateterismo Cardíaco/métodos , Humanos , Plomo , Cuerpo Médico , Sistema Nervioso/diagnóstico por imagen , Ropa de Protección , Equipos de Seguridad , Dosis de Radiación , Exposición a la Radiación/prevención & control , Monitoreo de Radiación/métodos , Protección Radiológica/métodos , Radiografía , Radiometría , Cintigrafía , Rayos XRESUMEN
The purpose of this paper is to report a set of experimental values of patient and staff doses in a cardiac catheterisation laboratory using the range of radiographic and geometric parameters from routine clinical practice. The data obtained will be available for validation of Monte Carlo calculations and for training purposes. They will also help optimise radiation protection for patients and staff. Experimental measurements were made with an anthropomorphic phantom, and a monoplane flat detector-based X-ray system was used for interventional cardiology procedures. Standard operational protocols used in clinical practice were applied. Around 1000 patient dose and 5000 staff dose values were measured for different operational conditions (angulations, distances, collimation and wedge filter, magnification, phantom thicknesses, using Copper absorber, etc.). Uncertainties were also estimated. Increase factors of 3-10 for patients and staff doses were measured for the different C-arm angulations.
Asunto(s)
Cardiología/métodos , Exposición Profesional , Radiología Intervencionista/métodos , Antropometría , Calibración , Diseño de Equipo , Fluoroscopía , Humanos , Cristalino/efectos de la radiación , Método de Montecarlo , Fantasmas de Imagen , Dosis de Radiación , Protección Radiológica/métodos , Radiometría , Dispersión de Radiación , Recursos Humanos , Rayos XRESUMEN
The purpose of this article is to present the results of connecting the interventional radiology and cardiology laboratories of five university hospitals to a unique server using an automatic patient dose registry system (Dose On Line for Interventional Radiology, DOLIR) developed in-house, and to evaluate its feasibility more than a year after its introduction. The system receives and stores demographic and dosimetric parameters included in the MPPS DICOM objects sent by the modalities to a database. A web service provides a graphical interface to analyse the information received. During 2013, the system processed 10 788 procedures (6874 cardiac, 2906 vascular and 1008 neuro interventional). The percentages of patients requiring clinical follow-up due to potential tissue reactions before and after the use of DOLIR are presented. The system allowed users to verify in real-time, if diagnostic (or interventional) reference levels are fulfilled.
Asunto(s)
Cardiología/estadística & datos numéricos , Registros Electrónicos de Salud/estadística & datos numéricos , Almacenamiento y Recuperación de la Información/estadística & datos numéricos , Exposición a la Radiación/estadística & datos numéricos , Radiología Intervencionista/estadística & datos numéricos , Sistema de Registros , Hospitales Universitarios/estadística & datos numéricos , Humanos , Registro Médico Coordinado/métodos , Protección Radiológica/estadística & datos numéricos , Radiometría/estadística & datos numéricos , España/epidemiologíaRESUMEN
Gemfibrozil, a hypolipidemic drug mainly used in the treatment of hypertriglyceridemic states, strongly inhibits the rat hepatic microsomal fatty acid chain elongation system in vitro. The inhibition is independent on the reducing cofactor used in the assay. Furthermore, gemfibrozil seems to act by inhibiting the rate-limiting step of the elongation process, the condensing reaction, without discriminating among the proposed three different condensing enzymes, devoted to condensation of saturated, mono-unsaturated and polyunsaturated acyl-CoA substrates.
Asunto(s)
Ácidos Grasos/biosíntesis , Gemfibrozilo/farmacología , Microsomas Hepáticos/metabolismo , Animales , Masculino , Microsomas Hepáticos/efectos de los fármacos , Ratas , Ratas EndogámicasRESUMEN
Uncoupling proteins (UCPs) are mitochondrial membrane proton transporters that uncouple respiration from oxidative phosphorylation by dissipating the proton gradient across the membrane. We studied the direct effect of several peroxisome proliferator-activated receptor (PPAR) ligands on UCP-3 and UCP-2 mRNA expression in C2C12 myotubes for 24 h. In the absence of exogenous fatty acids, treatment of C2C12 cells with a selective PPARalpha activator (Wy-14,643) or a non-selective PPAR activator (bezafibrate) did not affect the expression of UCP-3 mRNA levels, whereas UCP-2 expression was slightly increased. In contrast, troglitazone, a thiazolidinedione which selectively activates PPARgamma, strongly decreased UCP-3 and UCP-2 mRNA levels. Another thiazolidinedione, ciglitazone, had the same effect, but to a lower extent, suggesting that PPARgamma activation is involved. Further, the presence of 0.5 mM oleic acid strongly increased UCP-3 mRNA levels and troglitazone addition failed to block the effect of this fatty acid. The drop in UCP expression after thiazolidinedione treatment correlated well with a reduction in PPARalpha mRNA levels produced by this drug, linking the reduction in PPARalpha mRNA levels with the down-regulation of UCP mRNA in C2C12 myotubes after thiazolidinedione treatment.
Asunto(s)
Proteínas Portadoras/genética , Regulación hacia Abajo/efectos de los fármacos , Proteínas de Transporte de Membrana , Proteínas Mitocondriales , Músculos/efectos de los fármacos , Proteínas/genética , Tiazoles/farmacología , Tiazolidinedionas , Acil-CoA Deshidrogenasa , Animales , Atorvastatina , Bezafibrato/farmacología , Carnitina O-Palmitoiltransferasa/genética , Línea Celular , Colesterol/farmacología , Cromanos/farmacología , Ácido Graso Desaturasas/genética , Ácidos Heptanoicos/farmacología , Hipoglucemiantes/farmacología , Canales Iónicos , Ligandos , Ratones , Músculos/citología , Músculos/enzimología , Músculos/metabolismo , Ácido Oléico/farmacología , Proliferadores de Peroxisomas/farmacología , Pirimidinas/farmacología , Pirroles/farmacología , ARN Mensajero/genética , ARN Mensajero/metabolismo , Receptores Citoplasmáticos y Nucleares/agonistas , Receptores Citoplasmáticos y Nucleares/genética , Receptores Citoplasmáticos y Nucleares/metabolismo , Factores de Transcripción/agonistas , Factores de Transcripción/genética , Factores de Transcripción/metabolismo , Triazenos/farmacología , Troglitazona , Proteína Desacopladora 2 , Proteína Desacopladora 3RESUMEN
Brefeldin A (BFA) has previously been shown to block protein secretion and to cause dismantling of the Golgi cisternae in many cultured cell lines. BFA was found to prevent the induced synthesis and secretion of 14 kDa group II phospholipase A2 (PLA2) in rat mesangial cells. Furthermore, BFA inhibited total protein synthesis although PLA2 appeared to be more sensitive to the effect of this compound than total protein synthesis assessed by amino acid incorporation. BFA was unable to block protein synthesis or PLA2 activity in the cell completely but secretion of enzymatic activity and PLA2 protein into the cell culture media was totally inhibited.